Last updated: July 17, 2026

Application No. 18/912,410

METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS

Non-Final OA

Filed

Oct 10, 2024

Priority

Apr 06, 2018 — provisional 62/654,012 +3 more

Examiner

TIWARI, VYOMA SHUBHAM

Art Unit

Tech Center

Assignee

The Regents of the University of California

OA Round

1 (Non-Final)

This examiner grants 30% of cases after interview

— +46.7% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 53 resolved cases, 2023–2026

Examiner Intelligence

TIWARI, VYOMA SHUBHAM View full profile →

Grants only 30% of cases

Career Allowance Rate

16 granted / 53 resolved

-29.8% vs TC avg

Strong +47% interview lift

Without

With

+46.7%

Interview Lift

resolved cases with interview

Typical timeline

4y 0m

Avg Prosecution

25 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§101

0.4%

-39.6% vs TC avg

§103

56.3%

+16.3% vs TC avg

§102

8.6%

-31.4% vs TC avg

§112

34.0%

-6.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 53 resolved cases

Prosecution Timeline

Oct 10, 2024

Application Filed

May 07, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/298,271

Patent 12577311

CHIMERIC ANTIGEN RECEPTOR FACTORIES AND METHODS OF USE THEREOF

4y 9m to grant Granted Mar 17, 2026

16/639,836

Patent 12545734

CELLULAR BASED THERAPIES TARGETING DISEASE-ASSOCIATED MOLECULAR MEDIATORS OF FIBROTIC, INFLAMMATORY AND AUTOIMMUNE CONDITIONS

5y 11m to grant Granted Feb 10, 2026

19/209,435

Patent 12544418

COMPOSITIONS AND METHODS FOR TREATMENT

9m to grant Granted Feb 10, 2026

17/253,455

Patent 12502408

MITOCHONDRIAL AUGMENTATION THERAPY FOR PRIMARY MITOCHONDRIAL DISEASES

5y 0m to grant Granted Dec 23, 2025

17/405,735

Patent 12471592

CYTOPROTECTIVE COMPOSITIONS FOR SHORT-TERM CELLS STORAGE AND TRANSPORTATION WITHOUT CRYOPRESERVATION AND DEEP FREEZING

4y 3m to grant Granted Nov 18, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

30%

Grant Probability

77%

With Interview (+46.7%)

4y 0m (~2y 3m remaining)

Median Time to Grant

Low

PTA Risk

Based on 53 resolved cases by this examiner. Grant probability derived from career allowance rate.